A company in transition - Scientist 4 bei Genentech: Mitarbeiterbewertung

4,0
14. Okt. 2024
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Opportunity to learn High level of collaboration Focus on patients

Kontras

Upward mobility for IC's is and has been the Achille's heel of Genentech. It's glacial. Hyper-focus on AI/ML has come somewhat at the expense of letting the science speak. Everything feels rushed, which doesn't necessarily translate to developing great medicines. Uncharacteristically high amount of layoffs recently, heavily weighted towards IC's. Way too much mid-level management people who contribute little.

Mehr Bewertungen zu Genentech entdecken

5,0
6. Juli 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great pay, great culture and the best benefits and perks

Kontras

Longer to climb the ladder

2,0
19. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

The work is meaningful and overall the company vision aligns with my goals

Kontras

QA management has become inept. None of the leadership (aside from maybe one or two) truly understand the nuances of our site and jobs. They refuse to pay you more due to "budget" reasons but won't provide much information, they claim to be transparent but will make decisions behind your back and not communicate them, even if they impact you and/or your job. Leadership doesn't listen to feedback and gets defensive if you even try to give any. It honestly has become a game of politics only in QA and that's not really building any real quality culture.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle